Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.08M | 2.79M | 1.48M | 1.18M | 1.07M |
| Gross Profit | -3.08M | -2.79M | -1.48M | -1.18M | -1.07M |
| SG&A Expenses | 1.19M | 1.37M | 1.06M | 1.32M | 1.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.27M | 4.17M | 2.53M | 2.51M | 2.31M |
| Operating Income | -4.27M | -4.17M | -2.53M | -2.51M | -2.31M |
| Income Before Tax | -4.14M | -4.00M | -2.37M | -2.39M | -2.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.14M | -4.00M | -2.37M | -2.39M | -2.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.14M | -4.00M | -2.37M | -2.39M | -2.17M |
| EBIT | -4.27M | -4.17M | -2.53M | -2.51M | -2.31M |
| EBITDA | -4.27M | -4.17M | -2.53M | -2.50M | -2.31M |
| EPS Basic | -0.36 | -0.34 | -0.25 | -0.44 | -0.45 |
| Normalized Basic EPS | -0.22 | -0.22 | -0.16 | -0.27 | -0.28 |
| EPS Diluted | -0.36 | -0.34 | -0.25 | -0.44 | -0.45 |
| Normalized Diluted EPS | -0.22 | -0.22 | -0.16 | -0.27 | -0.28 |
| Average Basic Shares Outstanding | 11.62M | 11.62M | 9.36M | 5.47M | 4.79M |
| Average Diluted Shares Outstanding | 11.62M | 11.62M | 9.36M | 5.47M | 4.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |